{"id":"cmi-x-11s","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T02:31:26.411Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123800,"model":"claude-sonnet-4-5-20250929"},"description":"CMI X-11S is an investigational drug candidate being developed by Cardiometabolics, currently in Phase 2 clinical trials. Limited public information is available regarding its molecular target, mechanism of action, or specific therapeutic indications within the cardiometabolic disease space.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT00500929","phase":"PHASE2","title":"A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP","status":"COMPLETED","sponsor":"Cardiometabolics","startDate":"2007-07","conditions":"Heart Disease","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CMI X-11S","genericName":"CMI X-11S","companyName":"Cardiometabolics","companyId":"cardiometabolics","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}